Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2014 08:16 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences Reports Third-Quarter 2014 Financial Results

ANN ARBOR, Mich., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
November 05, 2014 16:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences to Host Third Quarter 2014 Earnings Call on November 13, 2014

ANN ARBOR, Mich., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
October 09, 2014 17:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences Announces Plans to Change Name to Vericel Corporation and Move Headquarters to Cambridge, Massachusetts

ANN ARBOR, Mich., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
September 17, 2014 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

ANN ARBOR, Mich., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
September 16, 2014 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences to Present Three-Year Data From the SUMMIT Extension Study of MACI(TM) at the 2015 American Academy of Orthopedic Surgeons Annual Meeting

ANN ARBOR, Mich., Sept. 16, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
September 11, 2014 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences Announces Pricing of Public Offering of Common Stock

ANN ARBOR, Mich., Sept. 11, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
August 22, 2014 09:00 ET | Source: Aastrom Biosciences, Inc.

Treatment With Aastrom's Ixmyelocel-T Shown to Reduce Incidence of Major Adverse Cardiovascular Events in Patients With Ischemic Dilated Cardiomyopathy

ANN ARBOR, Mich., Aug. 22, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
August 14, 2014 07:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences Reports Second Quarter 2014 Financial Results

U.S. Commercial Business Generates Positive Contribution Conference Call Today at 8:30 a.m. Eastern Time ANN ARBOR, Mich., Aug. 14, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc....
August 11, 2014 09:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Biosciences to Host Second Quarter 2014 Earnings Call on August 14, 2014

ANN ARBOR, Mich., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...
July 14, 2014 08:30 ET | Source: Aastrom Biosciences, Inc.

Aastrom Announces Appointment of Zac Taylor as National Sales Director

ANN ARBOR, Mich., July 14, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases...